SOPHiA GENETICS (SOPH) Net Cash Flow (2020 - 2025)

SOPHiA GENETICS's Net Cash Flow history runs 6 years deep, the most recent figure standing at -$12.0 million for Q4 2025.

• In Q4 2025, Net Cash Flow rose 7.13% year-over-year to -$12.0 million; the TTM figure through Dec 2025 stood at -$14.2 million (up 63.51% YoY), while the FY2025 annual figure was -$14.2 million, up 63.51% from the prior year.
• Net Cash Flow came in at -$12.0 million for Q4 2025 at SOPHiA GENETICS, up from -$13.3 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $168.8 million in Q3 2021 to a low of -$20.8 million in Q3 2022.
• A 5-year average of -$156050.0 and a median of -$12.2 million in 2021 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow sank 1915.5% in 2023 and jumped 1596.8% in 2025, its largest moves.
• SOPHiA GENETICS's Net Cash Flow stood at -$17.2 million in 2021, then soared by 103.42% to $587000.0 in 2022, then tumbled by 1915.5% to -$10.7 million in 2023, then retreated by 21.54% to -$13.0 million in 2024, then grew by 7.13% to -$12.0 million in 2025.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$12.0 million, -$13.3 million, and $23.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison